...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
【24h】

Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.

机译:工艺和配方参数对溶剂蒸发法形成的聚(d,l-丙交酯-共-乙交酯)微球的特性和内部形态的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Taking ABT627 as a hydrophobic model drug, poly-(lactic-co-glycolic acid) (PLGA) microspheres were prepared by an emulsion solvent evaporation method. Various process parameters, such as continuous phase/dispersed phase (CP/DP) ratio, polymer concentration, initial drug loading, polyvinyl alcohol concentration and pH, on the characteristics of microspheres and in vitro drug release pattern of ABT627 were investigated. Internal morphology of the microspheres was observed with scanning electron microscopy by stereological method. CP/DP is a critical factor in preparing microspheres and drug loading increased significantly with increasing CP/DP ratios accompanied by a remarkably decreased burst release. At CP/DP ratio 20, microspheres with a core-shell structure were formed and the internal porosity of the microspheres decreased with increasing CP/DP ratio. Increase in PLGA concentration led to increased particle sizes and decreased drug release rates. ABT627 release rate increased considerably with increasing PVA concentrations in the continuous phase from 0.1% to 0.5%. The maximum solubility of ABT627 in PLGA was approximately 30%, under which ABT627 was dispersed in PLGA matrix in a molecular state. Increase in initial drug loading had no significant influence on particle size, drug encapsulation efficiency, burst release and internal morphology. However, drug release rate decreased at higher drug loading. Independent of process parameters, ABT627 was slowly released from the PLGA microspheres over 30 days, by a combination of diffusion and polymer degradation. During the first 13 days, ABT627 was mainly released by the mechanism of diffusion demonstrated by the unchanged internal morphology. In contrast, a core-shell structure of the microspheres was observed after being incubated in the release medium for 17 days, independent of drug loading, implying that the ABT627/PLGA microspheres degraded by autocatalytic effect, starting from inside of the matrix. In conclusion, hydrophobic drug release from the PLGA microspheres is mainly dependent on the internal morphology and drug distribution state in the microspheres.
机译:以ABT627为疏水模型药物,通过乳液溶剂蒸发法制备了聚乳酸-乙醇酸共聚物(PLGA)微球。研究了各种工艺参数,如连续相/分散相(CP / DP)比,聚合物浓度,初始载药量,聚乙烯醇浓度和pH值,ABT627微球的特性和体外释药模式。微球的内部形态通过立体电子显微镜进行扫描电子显微镜观察。 CP / DP是制备微球的关键因素,并且随着CP / DP比的增加,药物释放量显着增加,同时爆发释放显着降低。在CP / DP比为20时,形成具有核-壳结构的微球,并且随着CP / DP比的增加,微球的内部孔隙率降低。 PLGA浓度的增加导致粒径增加和药物释放速率降低。随着连续相中PVA浓度从0.1%增加到0.5%,ABT627释放速率显着增加。 ABT627在PLGA中的最大溶解度约为30%,在此下ABT627以分子状态分散在PLGA基质中。初始载药量的增加对粒径,药物包封效率,爆发释放和内部形态没有显着影响。然而,在较高载药量下药物释放速率降低。与工艺参数无关,通过扩散和聚合物降解的组合,ABT627在30天内从PLGA微球中缓慢释放。在最初的13天中,ABT627主要是由内部形态不变的扩散机制释放的。相反,在释放介质中孵育17天后,观察到微球的核-壳结构,与药物载量无关,这意味着ABT627 / PLGA微球由于自身催化作用而降解,从基质内部开始。总之,从PLGA微球释放的疏水性药物主要取决于微球的内部形态和药物分布状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号